Medicine and Dentistry
Sepsis
100%
Neonatal Sepsis
88%
Neonatal Intensive Care Unit
43%
Infection
41%
Prematurity
38%
Cohort Analysis
35%
Brain Injury
26%
Newborn Intensive Care
26%
Palivizumab
26%
Pregnancy
22%
Systematic Review
20%
Gestational Age
20%
Parenteral Drug Administration
19%
Randomized Clinical Trial
18%
Chorioamnionitis
18%
Human Respiratory Syncytial Virus
17%
Gene Linkage
17%
Human Milk
17%
Sildenafil
17%
Alkaline Phosphatase
17%
Retrospective Cohort Study
15%
Randomized Controlled Trial
14%
Staphylococcus Epidermidis
14%
Necrotizing Enterocolitis
13%
Bacterial Infection
13%
Probiotics
13%
Health Service
12%
Chronic Lung Disease
12%
Pentoxifylline
12%
Bloodstream Infection
12%
High Risk Infant
11%
Retinopathy of Prematurity
11%
Lactoferrin
11%
Intravenous Drug Administration
10%
Caffeine Citrate
10%
Pathogen
10%
Adverse Effect
10%
Birth Weight
10%
Respiratory Tract Infection
10%
Diagnosis
9%
Histopathology
9%
Antiinfective Agent
9%
Vancomycin
9%
Base
9%
Immunoprophylaxis
9%
Neonates
9%
Coagulase Negative Staphylococcus
9%
Peptides and Proteins
8%
Innate Immunity
8%
Gut
8%
Immunology and Microbiology
Staphylococcus Epidermidis
63%
Infectious Agent
60%
Blood Plasma
41%
Chorioamnionitis
39%
Cytokine
27%
Palivizumab
26%
Cytokine Response
22%
Immune Response
20%
Innate Immune System
20%
Pentoxifylline
20%
Immunity
19%
Human Respiratory Syncytial Virus
17%
Coagulase Negative Staphylococcus
17%
Probiotic
17%
Phagocytosis
17%
Skin Microbiome
17%
Leukocyte
16%
Interleukin 6
15%
Interleukin 10
13%
Pregnancy
13%
Interleukin-1
13%
Transcriptome
13%
Escherichia coli
12%
Inflammatory Cytokine
12%
Immunoassay
12%
Neutrophil
12%
Agonist
11%
Enterocolitis
10%
Tumor Necrosis Factor
10%
Inflammation Response
9%
Bifidobacterium Breve
9%
Newborn Period
8%
Host Immune Response
8%
Immunosuppression
8%
Alkaline Phosphatase Blood Level
8%
Respiratory Syncytial Virus
8%
Multi-Omics
8%
Mouse Model
8%
Antibodies
8%
Peptides
8%
Proteomics
8%
Sampling
8%
Toll-Like Receptor
8%
Immaturity
7%
RNA Sequencing
6%
Lysozyme
6%
Microbiome
6%
Leukocyte Count
6%
Perinatal Period
6%
Proinflammatory Cytokine
6%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
76%
Pentoxifylline
55%
Coconut Oil
26%
Prematurity
24%
Chorioamnionitis
20%
Infection
20%
Cohort Study
20%
Necrotizing Enterocolitis
19%
Palivizumab
17%
Alkaline Phosphatase
17%
Pharmacokinetics
17%
Staphylococcus Epidermidis
13%
Bacterial Infection
12%
Inflammation
10%
Caffeine Citrate
10%
Randomized Controlled Trial
10%
Vancomycin
9%
Base
9%
Clinical Trial
9%
Human Respiratory Syncytial Virus
9%
Respiratory Tract Infection
9%
Mouse Model
8%
Lactoferrin
8%
Coagulase Negative Staphylococcus
8%
Secretory Phospholipase A2
8%
Critical Illness
8%
Microflora
8%
Hypoxic Ischemic Encephalopathy
8%
Placebo
8%
Lactobacillus plantarum
8%
Lipid Emulsion
8%
Microbiome
8%
Sildenafil
8%
2,5-Dimethoxy-4-iodoamphetamine
8%
Congenital Malformation
8%
Brain Injury
8%
Randomized Clinical Trial
5%
Chronic Lung Disease
5%
Bloodstream Infection
5%
Neuroprotective Agent
5%
Hospital Infection
5%